Market Place
Sourcing Support
Q32 Bio Announces Closing of Merger with Homology & Placement of $42M
25 Mar 2024 //
PR NEWSWIRE
Homology Medicines Declares Distribution to Common Stockholders
18 Mar 2024 //
GLOBENEWSWIRE
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price
03 Jan 2024 //
GLOBENEWSWIRE
Q32 Bio and Homology Medicines Announce Merger Agreement
16 Nov 2023 //
GLOBENEWSWIRE
Homology Medicines Reports Third Quarter 2023 Financial Results
14 Nov 2023 //
GLOBENEWSWIRE
Homology Medicines Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Homology Medicines Announces Data from First Dose Level in Trial
27 Jul 2023 //
GLOBENEWSWIRE
Homology Medicines Announces Data from First Dose Level in Trial Evaluating HMI-103
27 Jul 2023 //
GLOBENEWSWIRE
Homology Medicines 1st Data from IND-Enabling Studies with GTx-mAb HMI-104
16 May 2023 //
GLOBENEWSWIRE
Homology Medicines Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Homology Medicines Announces Presentations Highlighting its Genetic Platform
03 May 2023 //
GLOBENEWSWIRE
Homology Medicines Announces Presentations on Design of Trials for PKU
15 Mar 2023 //
GLOBENEWSWIRE
Homology Announces Promotion of Julie Jordan, M.D., to Chief Medical Officer
09 Mar 2023 //
GLOBENEWSWIRE
Homology Reports Fourth Quarter and Full Year 2022 Financial Results
09 Mar 2023 //
GLOBENEWSWIRE
Homology Medicines to Participate in the 43rd Annual Cowen Healthcare Conference
02 Mar 2023 //
GLOBENEWSWIRE
Homology Presents Data for Immunosuppression Regimen in Hunter Syndrome Trials
22 Feb 2023 //
GLOBENEWSWIRE
Homology Medicines Provides Update on pheEDIT and juMPStart Clinical Trials
04 Jan 2023 //
GLOBENEWSWIRE
Homology Medicines Reports 3Q 2022 Financial Results and Recent Highlights
10 Nov 2022 //
GLOBENEWSWIRE
Homology Medicines Presents on Design of pheEDIT Trial Evaluating HMI-103
27 Oct 2022 //
GLOBENEWSWIRE
Homology Medicines to Participate at Upcoming Conferences
06 Oct 2022 //
GLOBENEWSWIRE
Homology Medicines Appoints Albert Seymour CEO
06 Sep 2022 //
GLOBENEWSWIRE
Homology pauses rare metabolic disease trial despite clinical hold lift
17 Aug 2022 //
ENDPTS
Homology Medicines Reports Second Quarter 2022 Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Homology Medicines Announces Optimized, In Vivo Gene Therapy Candidate
11 Aug 2022 //
GLOBENEWSWIRE
Homology Medicines Announces Publication on Novel Discovery of AAVHSC
05 Jul 2022 //
GLOBENEWSWIRE
Homology Medicines to Present on its Gene Editing and Therapy Programs for PKU
29 Jun 2022 //
GLOBENEWSWIRE
Homology to resume gene therapy trial after FDA lifts hold
14 Jun 2022 //
ENDPTS
Homology Medicines` Optimized HMI-103 Nuclease-Free Gene Editing Candidate
18 May 2022 //
GLOBENEWSWIRE
Homology Medicines Reports First Quarter 2022 Financial Results
16 May 2022 //
GLOBENEWSWIRE
Homology Medicines Announces Upcoming Presentation on HMI-103
02 May 2022 //
GLOBENEWSWIRE
Homology Medicines Announces Promotion of Albert Seymour, Ph.D., to President
21 Apr 2022 //
GLOBENEWSWIRE
Homology Medicines Reports Q4 and Full Year 2021 Financial Results
23 Mar 2022 //
GLOBENEWSWIRE
Homology Medicines Closes Deal Leveraging its Internal Process Development
10 Mar 2022 //
GLOBENEWSWIRE
Homology Medicines to Participate in Upcoming Investor Conferences
03 Mar 2022 //
GLOBENEWSWIRE
FDA places gene therapy trial on hold
23 Feb 2022 //
PHARMAFILE
Homology joins BioMarin in halting gene therapy studies for rare metabolic
22 Feb 2022 //
ENDPTS
Homology Medicines Provides an Update on pheNIX Gene Therapy Trial in PKU
18 Feb 2022 //
PRESS RELEASE
Homology Medicines to Present on HMI-203 Investigational Gene Therapy
10 Feb 2022 //
GLOBENEWSWIRE
Homology scratches cash itch with $130M deal to fund trials
29 Jan 2022 //
FIERCEBIOTECH
Homology Medicines Announces Presentations Across Gene Therapy and Gene Editing
21 Oct 2021 //
GLOBENEWSWIRE
Homology Announces Presentation of Data Supporting Clinical Programs in MPS II
20 Oct 2021 //
GLOBENEWSWIRE
Homology Medicines Initiates Clinical Trial for HMI-203,
18 Oct 2021 //
GLOBENEWSWIRE
Homology Medicines to start clinical trial for gene editing candidate
12 Oct 2021 //
SEEKINGALPHA
Homology Medicines Announces World’s First Gene Editing Clinical Trial for PKU
12 Oct 2021 //
YAHOO
Homology Medicines Appoints B. Davidson, as Chair of Scientific Advisory Board
05 Aug 2021 //
GLOBENEWSWIRE
Homology Medicines Announces Presentations on its Expanding Genetic Medicines
13 May 2021 //
GLOBENEWSWIRE
Homology Medicines Announces New Approach to Leverage AAVHSC Platform
28 Apr 2021 //
GLOBENEWSWIRE
Homology Medicines Announces Presentations at ACMG
14 Apr 2021 //
GLOBENEWSWIRE
Homology Medicines Unveils New In Vivo Gene Therapy Development Program
23 Oct 2020 //
BIOSPACE
